NCT04804787Completed
Emotions in Multiple Sclerosis
Emotions Recognition in Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
Through this study, a group composed of multiple sclerosis patients will be compared to a healthy volunteers group to determine if the positive emotions recognitions is preserved in the first group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 16 Mar 2021
- Start date
- 23 Jun 2021
- Primary completion date
- 25 Feb 2025
- Lead sponsor
- Lille Catholic University
- Diseases
- Multiple sclerosis
- NCT number
- NCT04804787
What you commit to
- Study type: Interventional
- Participants enrolled: 101
- From 23 Jun 2021 to the primary completion date, 25 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Persons with previous neurological pathologies, head trauma with loss of consciousness, psychiatric pathologies, serious general affections, perceptive or dysarthric disorders preventing verbal communication or reading,
- Treatment with psychotropic drugs (except benzodiazepines and hypnotics).
Other illness
- People with sensory disorders (visual and auditory) that interfere with the performance of neuropsychological tests;
Other
- Refusal to participate after clear and fair information about the study.
- Major persons under guardianship, under judicial protection, persons deprived of liberty.
- Pregnant or breastfeeding women
Who the study is looking for
- Male or female between 18 and 55 years old.
- Understand and able to express themselves in French.
- EXPERIMENTAL GROUP :
- Relapsing-remitting form (RRMS)
- With an EDSS \< 4 (Expanded Disability Status Scale)
- No significant motor, cerebellar or somatosensory disorders of the upper limbs or visual disorders (EDSS specific parameter \<2)
- No flare-up in the last 6 weeks
- No corticosteroids taken in the last 4 weeks
- CONTROL GROUP :
- Lack of global cognitive deterioration (according to Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) standards).
- Gender, age and education level matching to the multiple sclerosis patients
- Understanding and signing the informed consent and information letter regarding participation in the study.
- Benefiting from health insurance coverage.
Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hopital Saint Vincent de Paul Coordinator of this site? Confirm its status | Lille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.